Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway

Author:    

Publisher: Spandidos Publications

E-ISSN: 1791-3004|12|6|7869-7876

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.12, Iss.6, 2015-01, pp. : 7869-7876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract